Drug intelligence / Profile preview

Calceos

Development stage: Unknown
Lead developer: Myralis
Modality: Small Molecules
Administration: Oral

Overview

Calceos is a pediatric-focused dietary supplement and over-the-counter (OTC) medication developed by the Brazilian pharmaceutical company Myralis. It is primarily available as an oral suspension, often marketed under the brand name Calceos Kids. The product is formulated with a combination of calcium and vitamin D3 (cholecalciferol) to support bone development, maintain mineral homeostasis, and prevent or treat nutritional deficiencies in children. As a product of Brazil's largest vitamin D manufacturer, Calceos is widely distributed in the Brazilian retail pharmacy market and is typically offered in child-friendly flavors such as cherry.

Brand names: CalceosCalceos Kids
Other names: Calceos Kids oral suspensionSuplemento alimentar em suspensão oral Calceos

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Calceos.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calceos.

Explore the full profile